First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers.
Not yet recruiting · NCT07377253 · Registry updated 2026-01-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| First-in-Human Study Testing a New Antibody Treatment for Tick-Borne Encephalitis in Healthy Volunteers. | Encephalitis, Arbovirus, Encephalitis, Viral, Flaviviridae infectious disease, Flavivirus Infections, Infections, Neuroinflammatory Diseases, RNA Virus Infections, arbovirus infection, brain disorder, central nervous system disorder, central nervous system infectious disorder, encephalitis, infectious encephalitis, nervous system disorder, tick-borne encephalitis, tick-borne infectious disease, vector-borne disease, viral infection of central nervous system, viral infectious disease | Not yet recruiting | Phase 1 | 2026-01-29 | NCT07377253 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Giuseppe Pantaleo | 1 |
| Rockefeller University | 21 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Centre Universitaire Hospitalier Vaudois (CHUV) | Lausanne | Switzerland | 1 |